Inicio > BIGG > Resultado de la búsqueda

    Resultados: 2

    Tafasitamab with lenalidomide for treating relapsed or refractory diffuse large B-cell lymphoma

    England. National Institute for Health and Care Excellence.
    People with relapsed or refractory diffuse large B-cell lymphoma who cannot have an autologous stem cell transplant usually have polatuzumab vedotin plus rituximab and bendamustine. The clinical evidence is from a small study that did not directly compare tafasitamab plus lenalidomide with any other trea...
    Linfoma de Células B Grandes Difuso/tratamiento farmacológico, Lenalidomida/uso terapéutico, Anticuerpos Monoclonales/uso terapéutico, Factores Inmunológicos/uso terapéutico
    Texto completo

    A living WHO guideline on drugs for COVID-19

    Rochwerg, Bram; Agoritsas, Thomas; Lamontagne, François; Leo, Yee-Sin; Macdonald, Helen; Agarwal, Arnav; Zeng, Linan; Lytvyn, Lyubov; Appiah, John Adabie; Amin, Wagdy; Arabi, Yaseen; Blumberg, Lucille; Burhan, Erlina; Bausch, Frederique; Calfee, Carolyn S; Cao, Bin; Cecconi, Maurizio; Chanda, Duncan; Cooke, Graham; Du, Bin; Dunning, Jake; Geduld, Heike; Gee, Patrick; Hashimi, Madiha; Hui, David S; Kabra, Sushil; Kanda, Seema; Kawano-Dourado, Leticia; Kim, Yae-Jean; Kissoon, Niranjan; Kwizera, Arthur; Laake, Jon Henrik; Machado, Flavia R; Mahaka, Imelda; Manai, Hela; Mino, Greta; Nsutebu, Emmanuel; Pshenichnaya, Natalia; Qadir, Nida; Sabzwari, Saniya; Sarin, Rohit; Sharland, Michael; Shen, Yinzhong; Ranganathan, Shalini Sri; Souza, Joao; Ugarte, Sebastian; Venkatapuram, Sridhar; Dat, Vu Quoc; Vuyiseka, Dubula; Wijewickrama, Ananda; Maguire, Brittany; Zeraatkar, Dena; Bartoszko, Jessica; Ge, Long; Brignardello-Petersen, Romina; Siemieniuk, Reed; Guyatt, Gordon; Diaz, Janet; Jacobs, Michael; Vandvik, Per Olav.
    BMJ; 370 (), 2020
    What is the role of drug interventions in the treatment of patients with covid-19? The latest version of this WHO living guidance focuses on remdesivir, following the 15 October 2020 preprint publication of results from the WHO SOLIDARITY trial. It contains a weak or conditional recommendation against th...
    Ivermectina/uso terapéutico, Índice de Severidad de la Enfermedad, COVID-19/tratamiento farmacológico, Factores Inmunológicos/uso terapéutico, Antirretrovirales/uso terapéutico, Corticoesteroides/uso terapéutico, Hidroxicloroquina/uso terapéutico, Lopinavir/uso terapéutico
    Texto completo